XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Note 13 - Segment Information (Tables)
3 Months Ended
Jun. 30, 2020
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Three Months Ended June 30, 2020

 
  

Sterilization and Disinfection Control

  

Instruments

  

Biopharmaceutical Development

  

Continuous Monitoring

  

Corporate and Other

  

Total

 

Revenues (1)

 $13,067  $7,680  $5,949  $3,245  $-  $29,941 

Gross profit (loss)

 $9,977  $4,671  $4,466  $874  $(20) $19,968 

Reconciling items (2)

                 (19,586)

Earnings before income taxes

                $382 
  

Three Months Ended June 30, 2019

 
  

Sterilization and Disinfection Control

  

Instruments

  

Biopharmaceutical Development

  

Continuous Monitoring

  

Corporate and Other

  

Total

 

Revenues (1)

 $12,110  $9,544  $-  $3,317  $1,317  $26,288 

Gross profit

 $8,505  $6,063  $-  $1,244  $327  $16,139 

Reconciling items (2)

                 (10,779)

Earnings before income taxes

                $5,360 
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
  

June 30, 2020

  

March 31, 2020

 

Sterilization and Disinfection Control

 $71,860  $73,103 

Instruments

  29,756   31,025 

Biopharmaceutical Development

  190,765   182,758 

Continuous Monitoring

  30,077   29,732 

Corporate and administrative

  254,275   103,588 

Total

 $576,733  $420,206